The unprecedented impact of COVID-19 has been felt across the medical community, increasing concerns over PTSD and moral injury rising among physicians and care teams.
Kaiser Permanente research in Northern California backs anecdotal reports of people avoiding emergency care because of concerns over the coronavirus.
Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.
As parts of the country slowly reopen, attention turns to effective population testing to monitor flare-ups.
The 55-Word Stories campaign is an initiative that provides Permanente physicians with a creative outlet to share how COVID-19 has impacted their practice and/or personal life.
More Kaiser Permanente members get comfortable with virtual visits such as phone and video appointments during the COVID-19 pandemic.
Pediatrician Kerstin Rosen, MD, of The Permanente Medical Group, designed a face shield for health care workers and enlisted the help of the 3D printing community.
In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.
Dennis Truong, MD, assistant medical director of Telemedicine at the Mid-Atlantic Permanente Medical Group, shares moments of inspiration during the challenging days of coronavirus.
A new Kaiser Permanente study of COVID-19 patients published today as a research letter in the Journal of the American Medical Association (JAMA) provides estimates for the percentage of test-positive patients requiring hospitalization and admission to the ICU.